Wikidata

(Q42244955)

English

Treatment of Huntington disease with -acetylenic GABA, an irreversible inhibitor of GABA- transaminase: Increased CSF GABA and homocarnosine without clinical amelioration

scientific article published on February 1, 1981

In more languages
default for all languages
No label defined

No description defined

Statements

title
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6258106
retrieved
19 October 2017
Treatment of Huntington disease with -acetylenic GABA, an irreversible inhibitor of GABA- transaminase: Increased CSF GABA and homocarnosine without clinical amelioration (English)
1 reference
stated in
Crossref
DOI
10.1212/WNL.31.2.207
reference URL
https://api.crossref.org/works/10.1212/WNL.31.2.207
retrieved
9 September 2023
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42244955&oldid=1970894486"